WHO ICTRP trial
An open-label, single-dose study to evaluate the pharmacokinetics and safety of…
JPRN-jRCT2080223081 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080223081 |
|---|---|
| Public title | An open-label, single-dose study to evaluate the pharmacokinetics and safety of DS-8500a in Japanese subjects with varying degrees of hepatic or renal function |
| Scientific title | An open-label, single-dose study to evaluate the pharmacokinetics and safety of DS-8500a in Japanese subjects with varying degrees of hepatic or renal function |
| Primary sponsor | DAIICHI SANKYO CO., LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Subjects with hepatic or renal impairment |
| Interventions | investigational material(s) Generic name etc : DS-8500a INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral |
| Registration date | Jan 18, 2016 |
| Target size | 48 |
| Secondary IDs | JapicCTI-163135 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: